News & Events


New Fountain of Youth : How human cell aging reversed by new compounds

Key aspects of the ageing of human cells can be reversed by new compounds developed at the University of Exeter, research shows.


Potential new class of drugs may reduce cardiovascular risk by targeting gut microbes

Cleveland Clinic researchers have designed a potential new class of drugs that may reduce cardiovascular risk by targeting a specific microbial pathway in the gut.


New anti-cancer drugs put cancers to sleep—permanently

Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer therapies.


New Immunotherapy Treatment Removes All Tumors In Woman With Advanced Metastatic Breast Cancer

T-cells extracted from a tumor, expanded and then re-introduced into the body have resulted in the disappearance of tumors in a woman with metastatic breast cancer.


Virus-free CRISPR could mean faster, more precise gene editing for T-cell therapies

New electroporation-based CRISPR-Cas9 method, eliminating viruses from the gene editing process and laying the groundwork for safer, more precise and more efficient editing for CAR-T cancer treatments and other cell therapies.


New small molecules for the treatment of autoinflammatory diseases

EPFL scientists have discovered two small-molecule compound series that can effectively block a central pathway of the innate immune system, offering a promising new way for treating autoinflammatory diseases


Pathway of Alzheimer’s degeneration discovered

Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University have used a unique approach to track brain degeneration in Alzheimer’s disease, uncovering a pathway through which degeneration spreads from one region to another.


Ketogenic diet may boost targeted cancer therapy

A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs


Gene discovery unlocks mysteries to our immunity

The gene, called C6orf106 or “C6”, controls the production of proteins involved in infectious diseases, cancer and diabetes. The gene has existed for 500 million years, but its potential is only now understood.

Get in touch

Subscribe to Eclosion Newsletter

 

CONTACT US
© 2016 Fondation Eclosion
All rights reserved
Webdesign: Comstone / Pierre Chassany
WordPress Development: Olivier Gisiger